Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1998
12/30/1998WO1998058926A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
12/30/1998WO1998058925A1 Barbituric acid derivatives with antimetastatic and antitumor activity
12/30/1998WO1998058922A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
12/30/1998WO1998058919A1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
12/30/1998WO1998058916A1 NEW β-AMINO AND β-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS
12/30/1998WO1998058915A2 Pyrimidin-2,4,6-trion derivatives and their use as metalloprotease-inhibitors
12/30/1998WO1998058913A1 Chalcones having antiproliferative activity
12/30/1998WO1998058910A1 Prostaglandin pharmaceutical compositions
12/30/1998WO1998058902A1 INHIBITORS OF α4β1MEDIATED CELL ADHESION
12/30/1998WO1998058677A1 Pharmaceutical formulations containing voriconazole
12/30/1998WO1998058676A1 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative
12/30/1998WO1998058675A1 Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent
12/30/1998WO1998058668A2 Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae
12/30/1998WO1998058658A1 Therapeutic method for management of diabetes mellitus
12/30/1998WO1998058652A1 Stable aspirin ointment preparations
12/30/1998WO1998058651A1 Stable aspirin-containing preparations for external use
12/30/1998WO1998058650A1 Use of plant-alkaloids to enhance innate immunity defense mechanisms
12/30/1998WO1998058648A1 Acetaminophen and dimenhydrinate analgesics
12/30/1998WO1998058647A1 Acetaminophen and cisapride analgesics
12/30/1998WO1998058646A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye
12/30/1998WO1998058645A1 (s)-(-)-n-[3- [5-[(4-fluorophenyl)methyl] -2-thienyl]-1-methyl -2-propynyl]-n-hydroxyurea
12/30/1998WO1998058644A1 (s)-(-)-n-[3- [5-(4-fluorophenoxy) -2-furanyl]-1-methyl -2-propynyl]-n-hydroxyurea
12/30/1998WO1998058643A1 Solid pharmaceutical composition containing benzofurane derivatives
12/30/1998WO1998058642A1 Oral formulations for controlled release of alcohol deterrents
12/30/1998WO1998058641A1 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
12/30/1998WO1998058640A1 Ibuprofen and diphenhydramine analgesics
12/30/1998WO1998058639A1 Synergistically acting compositions for selectively combating tumor tissue
12/30/1998WO1998058638A1 Method of treating heart failure
12/30/1998WO1998058637A1 Acetaminophen and diphenhydramine analgesics
12/30/1998WO1998058636A1 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
12/30/1998WO1998058635A2 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis
12/30/1998WO1998058634A2 Intratumoral administration of triphenylethylenes for the treatment of cancer
12/30/1998WO1998058633A2 Microdose therapy of vascular conditions by no donors
12/30/1998WO1998058630A1 Liposome-entrapped polynucleotide composition and method
12/30/1998WO1998058629A2 Preparation of pharmaceutical compositions
12/30/1998WO1998058543A1 Method to enhance innate immunity defense mechanisms by treatment with plant-derived alkaloids
12/30/1998WO1998043619A3 Method of local anesthesia
12/30/1998WO1998042325A3 INHIBITION OF THE CLEAVAGE OF PRECURSOR IL-1$g(b)
12/30/1998EP0887472A1 Tree planting concrete product
12/30/1998EP0887415A2 Human RCE1
12/30/1998EP0887414A2 Human serine proteases HGBAB90
12/30/1998EP0887411A2 N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Streptococcus pneumoniae
12/30/1998EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor
12/30/1998EP0887406A2 A member of the FRZB family, franzzled
12/30/1998EP0887350A1 Chromene derivatives, process for their preparation and pharmaceutical compositions containing them
12/30/1998EP0887349A1 Tetrahydroimidazo (2,1-a)isoquinoline derivatives
12/30/1998EP0887348A1 Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
12/30/1998EP0887347A1 Process for the preparation of dry thioctic acid
12/30/1998EP0887346A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists
12/30/1998EP0887345A1 4'-trifluoromethylbiphenyl-2-carboxylic acid-[2-(2-acetylaminoethyl)-1,2,3,4-tetrahydroisoquinolin-6-yl]amide hydrochloride as apo B-secretion/MTP inhibitors
12/30/1998EP0887344A1 Quinolines and quinazolines useful in therapy
12/30/1998EP0887081A2 Human serum glucocorticoid regulated kinase, a target for chronic renal disease
12/30/1998EP0887079A1 Beta-Adrenergic agonists to reduce a wasting condition
12/30/1998EP0887078A1 Use of L or DL-threo-DOPS for preventing and treating the consequences of cerebral ischemia
12/30/1998EP0887077A1 Use of azulene derivatives as metalloprotease inhibitors
12/30/1998EP0887076A2 Adhesion prevention and an endoscopic insufflation system therefor
12/30/1998EP0886679A1 Parapoxviruses containing foreign dna, their production and their use in vaccines
12/30/1998EP0886677A1 Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound
12/30/1998EP0886651A1 Persephin and related growth factors
12/30/1998EP0886647A1 Serine protease inhibitors
12/30/1998EP0886646A1 Novel compounds
12/30/1998EP0886645A1 New 19-nor-pregnene derivatives
12/30/1998EP0886637A1 Inhibitors of microsomal triglyceride transfer protein and method
12/30/1998EP0886636A1 Novel piperidines derived from 1-/(piperazin-1-yl)aryl(oxy/amino)carbonyl/-4-aryl-piperidine as selective 5-ht-1d.beta. receptor antagonists
12/30/1998EP0886635A1 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity
12/30/1998EP0886528A1 Use of coxiella bacteria to treat autoimmune disease
12/30/1998EP0886526A1 Protection of hemopoietic cells
12/30/1998EP0886525A1 PROGRAMMED CELL DEATH AND INTERLEUKIN-1$g(b)
12/30/1998EP0886524A2 Delivery of therapeutic agents to the prostate
12/30/1998EP0886520A1 Caffeine and clemastine for treating respiratory disorders
12/30/1998EP0886519A1 Sustained release formulation containing dfmo
12/30/1998EP0886517A1 Method for reducing skin oils and grease
12/30/1998EP0886515A1 Use of n-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss
12/30/1998EP0833619A4 Controlled release of drugs delivered by sublingual or buccal administration
12/30/1998EP0801570A4 Formulations and methods for reducing skin irritation
12/30/1998EP0766688A4 Synthesis of oligonucleotides
12/30/1998EP0760661B1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
12/30/1998EP0750637B1 Dna encoding cai resistance proteins and uses thereof
12/30/1998EP0731704A4 Synthetic glycoamines that promote or inhibit cell adhesion
12/30/1998EP0726892B1 (e)-20(22)-dehydrovitamin d compounds
12/30/1998EP0720617B1 Novel urethane-containing aminosteroid compounds
12/30/1998EP0705258B1 Azolyl-cyclic amine derivatives with immunomodulatory activity
12/30/1998EP0686142B1 Polyamine derivatives as radioprotective agents
12/30/1998EP0623112B1 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
12/30/1998EP0618889B1 Tri-substituted phenyl derivatives and processes for their preparation
12/30/1998EP0594577B1 Novel potent inducers of terminal differentiation and method of use thereof
12/30/1998EP0584175B1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
12/30/1998EP0577785B1 Fluorinated compounds as oxygen transport agents
12/30/1998EP0571474B1 Orthomolecular method of treating sickle cell disease
12/30/1998EP0522084B1 Antiviral compositions and method for their use
12/30/1998CN1203633A Diagnosis of susceptibility to cancer and treatment thereof
12/30/1998CN1203630A 治疗和诊断组合物 Therapeutic and diagnostic compositions
12/30/1998CN1203602A Acylated enol derivatives of 'alpha'-ketoesters and 'alpha'-ketoamides
12/30/1998CN1203600A Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
12/30/1998CN1203598A Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives
12/30/1998CN1203597A 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof
12/30/1998CN1203596A Furan-and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of replication of HIV-1 and HIV-1 mutants
12/30/1998CN1203590A Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/30/1998CN1203589A New compound
12/30/1998CN1203532A Method for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product
1 ... 6559 6560 6561 6562 6563 6564 6565 6566 6567 6568 6569 6570 6571 6572 6573 6574 6575 6576 6577 6578 6579 ... 7860